Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-25T10:19:54.734Z Has data issue: false hasContentIssue false

Immune modulation by the cholera-like enterotoxins

Published online by Cambridge University Press:  13 February 2004

Robert J. Salmond
Affiliation:
The Babraham Institute, Laboratory of Lymphocyte Signalling and Development, Babraham, Cambridge, CB2 4AT, UK.
Jeffrey A. Luross
Affiliation:
University of Bristol, Department of Pathology and Microbiology, School of Medical Sciences, University Walk, Bristol, BS8 1TD, UK.
Neil A. Williams
Affiliation:
University of Bristol, Department of Pathology and Microbiology, School of Medical Sciences, University Walk, Bristol, BS8 1TD, UK.

Abstract

The role of cholera toxin and heat-labile enterotoxin in the pathogenesis of diarrhoeal disease has been well documented for many years. In addition to these deleterious effects, a wealth of data is accumulating that suggests that these toxins and their subunits might be used to modulate immune responses in a variety of beneficial ways. In this regard, the toxins can boost immune responses to unrelated antigens, leading to the possibility of their use in the generation of improved vaccines to a variety of pathogens. Furthermore, recent evidence suggests that recombinant preparations of the nontoxic B subunits of the toxins have distinct immunomodulatory activities, with potential applications to the treatment of autoimmune and inflammatory diseases. This article reviews our current understanding of the mechanisms of immune modulation by these fascinating proteins.

Type
Review Article
Copyright
© Cambridge University Press 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)